A detailed history of Frazier Financial Advisors, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 36 shares of RDY stock, worth $553. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36
Previous 118 69.49%
Holding current value
$553
Previous $8.99 Million 68.18%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$75.41 - $84.21 $6,183 - $6,905
-82 Reduced 69.49%
36 $2.86 Million
Q2 2024

Aug 12, 2024

SELL
$68.26 - $76.19 $7,372 - $8,228
-108 Reduced 47.79%
118 $8.99 Million
Q1 2024

May 13, 2024

BUY
$67.36 - $77.59 $13,404 - $15,440
199 Added 737.04%
226 $16.6 Million
Q4 2023

Feb 09, 2024

BUY
$64.27 - $69.9 $1,735 - $1,887
27 New
27 $1.88 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.55B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.